Evaluating the Relative Treatment Efficacy of CD40 Agonist Mitazalimab in Combination with Mfolfirinox in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (mpdac) Using Unanchored Indirect Treatment Comparisons (Itcs).
Journal of Clinical Oncology（2025）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要